1. Home
  2. Companies
  3. Sarepta Therapeutics
ST

Sarepta Therapeutics

About

In 1980, Sarepta Therapeutics began its journey as AntiVirals Inc., founded by Dwight Weller and Milton Zuker with a vision for advancing antisense chemistry. The company evolved significantly over the decades - transforming through name changes and strategic pivots - from its initial focus on antiviral therapies to becoming a pioneering force in precision genetic medicine for rare diseases. This evolution wasn't just corporate restructuring; it was a response to a critical gap in treating devastating conditions that had long been overlooked by traditional pharmaceutical approaches. Today, Sarepta stands at the forefront of genetic medicine, having launched four FDA-approved therapies including the first-ever gene therapy for Duchenne muscular dystrophy, representing hope for patients who previously had none.

Sarepta is a global biotechnology company on an urgent mission: to engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. With headquarters in Cambridge, Massachusetts, and operations spanning the United States, Ireland, Switzerland, and the United Kingdom, the team is pioneering RNA-targeted therapeutics and gene therapies. Their focus centers on Duchenne muscular dystrophy and limb-girdle muscular dystrophy - debilitating conditions affecting thousands worldwide. Beyond drug development, Sarepta demonstrates deep commitment to patients through programs like SareptAssist, which provides personalized support navigating treatment access, and Route 79, a scholarship program supporting the educational goals of students living with Duchenne. The company's culture is built on values that prioritize patients, urgency, and scientific excellence, driving them daily to transform genetic understanding into life-changing treatments.

Similar companies

ST

Saronic Technologies

We're a defense technology company building autonomous surface vessels at scale. Founded in 2022 by a team of veterans and technologists, we're on a mission to protect our way of life by integrating autonomous systems into traditional naval fleets. Our boats go farther and do more with less risk to human life - something we care about deeply since many of us have served. Headquartered in Austin, Texas, we've grown rapidly because we solve real problems for the people who need them most. We design and manufacture our own vessels, control the entire software stack, and have already gone from prototype to production in under a year according to the Secretary of the Navy. We're not just building boats - we're building a hybrid fleet that helps the Navy and Marine Corps accomplish their missions more effectively.

SS

Sopra Steria

Sopra Steria, a major Tech player in Europe with 51,000 employees in nearly 30 countries, is recognised for its consulting, digital services and solutions. It helps its clients drive their digital transformation and obtain tangible and sustainable benefits. The Group provides end-to-end solutions to make large companies and organisations more competitive by combining in-depth knowledge of a wide range of business sectors and innovative technologies with a collaborative approach. Sopra Steria places people at the heart of everything it does and is committed to putting digital to work for its clients in order to build a positive future for all. In 2024, the Group generated revenues of €5.8 billion. At Sopra Steria, our mission is to guide our customers, partners and employees towards bold choices by leveraging digital technology to build a positive future for all. We believe in technology, but also in our ability to use our collective intelligence to help the world move forward. Together we are building a decisively promising future by delivering tangible results: lasting solutions that have a positive impact and fully integrate interactions between the digital world and society. We offer all our employees the opportunity to grow and improve their skills through a variety of experiences with top European companies.

MS

Mexichem Servicios Administrativos,

Orbia is a purpose-driven company dedicated to advancing life around the world through innovative solutions that address some of humanity's most pressing challenges. With a global team of over 23,000 employees, operations in more than 50 countries, and commercial activities spanning over 100 nations, Orbia delivers essential products and services that positively impact everyday life. The company operates five business groups: Polymer Solutions (Vestolit and Alphagary), Building & Infrastructure (Wavin), Precision Agriculture (Netafim), Connectivity Solutions (Dura-Line), and Fluor & Energy Materials. Together, these groups focus on expanding access to health and well-being, reinventing cities and homes, ensuring food and water security, connecting communities to information, and enabling the energy transition. Founded in 1953 and formerly known as Mexichem, Orbia generated $7.5 billion in sales and $1.19 billion in adjusted EBITDA in 2024, demonstrating its significant scale and financial strength. The company is deeply committed to sustainability, having aligned its operations with eight United Nations Sustainable Development Goals and developed an ImpactMark to transparently track environmental, social, and governance performance. Headquartered in Boston, Mexico City, Amsterdam, and Tel Aviv, Orbia combines deep industry expertise with a forward-thinking approach to create solutions that help build a more livable, lovable planet for current and future generations.

SG

Syngenta Group

Syngenta Group is one of the world's leading agricultural technology and innovation companies, employing more than 56,000 passionate people across more than 90 countries. With Swiss heritage and drawing from a 250-year legacy of scientific excellence, we design the bold breakthroughs growers need to tackle the challenges of modern farming. Our seeds, crop protection, and nutrition products, combined with agronomic solutions and digital services, help farmers provide the world with healthy food, feed, fiber, and fuel while conserving natural resources and protecting the environment. As a global leader in agricultural innovation, we operate through four core business units: Syngenta Crop Protection, Syngenta Seeds, ADAMA, and Syngenta Group China. Together, we represent one of the most geographically and culturally diverse businesses in agriculture, positioned to provide farmers with the best technology and expertise to increase productivity and grow sustainable food. With $611 million in research and development investments over the last decade and recognition as a top ag employer for 9 consecutive years, Syngenta Group continues to drive transformation in how we feed the world's growing population.

SG

Syngenta Group

With the global population projected to reach 9.7 billion by 2050, farmers face an unprecedented challenge: produce more food while reducing environmental impact and safeguarding natural resources. Syngenta exists to solve this existential problem - empowering farmers with the science-based innovations they need to feed the world while protecting our planet. As a global agriculture leader headquartered in Basel, Switzerland, we employ more than 56,000 people across 90+ countries, drawing from a 250-year legacy of scientific excellence to transform how crops are grown and protected. Our comprehensive portfolio spans crop protection, seeds, biologicals, and digital farming solutions that help farmers grow resilient, healthy crops in the face of climate change, disease, and resource pressures. Through breakthrough innovations like hybrid wheat varieties, CROPWISE™ digital tools, and biological crop protection products, we deliver measurable results: higher yields, lower environmental impact, and regenerative practices that restore soil health. From our MAP centers supporting smallholder farmers in China to our global R&D pipeline investing in the future of agriculture, every decision we make is grounded in our commitment to sustainability and farmer success.

VS

Veeva Systems

Public Benefit Corporation | B Corp Certified | Life Sciences The first publicly traded company and largest enterprise to achieve B Corp certification while listed on the NYSE (2021). As a Public Benefit Corporation, Veeva is legally committed to balancing profit with purpose. Why WDIWF selected this company: First publicly traded B Corp on NYSE, legally structured as Public Benefit Corporation, transparent accountability to stakeholders beyond shareholders, life sciences mission.